Porton Biologics
Providing end-to-end gene therapy CDMO services (subsidiary of Porton Pharma Solutions).
Launch date
Employees
Market cap
-
Enterprise valuation
$320—480m (Dealroom.co estimates Aug 2022.)
Suzhou Shi Jiangsu (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
CNY400m | Series A | ||
* | $80.0m | Series B | |
| Total Funding | $135m | ||